Cellebrite stock sets November 12 date for third-quarter results
Published on 11/02/2026 at 00:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCellebrite prepares for results
- The company will present its third-quarter 2026 results before U.S. markets open.
- Management plans to discuss the 2026 outlook during a conference call.
- Cellebrite says more than 7,000 organizations use its digital investigative software.
Cellebrite will release its third-quarter 2026 financial results before U.S. markets open on Thursday, November 12, the company said on October 20. The announcement was carried by PR Newswire via Yahoo Finance.
Results set the next catalyst
The earnings release is scheduled ahead of the U.S. session. Cellebrite will host a conference call and webcast at 8:30 a.m. Eastern Time the same day to review the quarter and discuss its 2026 outlook. Historical financial tables and supplemental information are expected in the company's quarterly-results section.
The scheduled report gives investors a defined near-term event for assessing demand for digital investigative software, execution in the third quarter and the outlook for the remainder of 2026. Analyst expectations and the company's guidance will shape the market's response once the figures are released.
Digital investigations remain core
Cellebrite develops AI-powered digital investigative and intelligence solutions for public-sector and private-sector customers. Its portfolio is available through cloud, on-premises and hybrid deployments and is designed to make forensically sound digital data more accessible and actionable. The company is headquartered in Israel and serves law enforcement, defense, intelligence and enterprise users worldwide.
Cellebrite at a glance
- Company: Cellebrite DI Ltd.
- ISIN: IL0011794802
- Ticker: CLBT
- Listing: Nasdaq
- Results: Third-quarter 2026 results scheduled for Thursday, November 12, 2026, before U.S. markets open
- Conference call: 8:30 a.m. Eastern Time on November 12, 2026
Broader U.S. equities can be followed in the S&P 500 market coverage.
More news and analyses on Cellebrite stock.
